|February 26, 2014|
|10:00 EDT||SWY, JNPR, FMS, SUNS, NEM, MSO, VLP, PSXP, JAZZ, ARIA, ITMN, FST, VNO, TOL, NIHD, HUM, DWA, SEAC, IZEA, VLRS, BOOM, DRH||On The Fly: Analyst Downgrade Summary|
DiamondRock (DRH) downgraded to Neutral from Buy at ISI Group... Dynamic Materials (BOOM) downgraded to Neutral from Overweight at JPMorgan... Fresenius Medical (FMS) downgraded to Neutral from Buy at UBS... Humana (HUM) downgraded to Sell from Neutral at Citigroup... Jazz Pharmaceuticals (JAZZ) downgraded to Hold from Buy at Cantor... Juniper (JNPR) downgraded to Neutral from Overweight at Piper Jaffray... NII Holdings (NIHD) downgraded to Neutral from Outperform at Macquarie... Phillips 66 Partners (PSXP) downgraded to Neutral from Outperform at Credit Suisse... Safeway (SWY) downgraded to Neutral from Overweight at JPMorgan... Toll Brothers (TOL) downgraded to Market Perform from Outperform at Keefe Bruyette... Valero Energy Partners (VLP) downgraded to Neutral from Outperform at Credit Suisse... Volaris (VLRS) downgraded to Hold from Buy at Deutsche Bank... Vornado (VNO) downgraded to In-Line from Outperform at Imperial Capital... Martha Stewart (MSO) downgraded to Hold from Buy at Noble Financial... IZEA (IZEA) downgraded to Neutral from Buy at Merriman... Forest Oil (FST) downgraded to Market Perform from Outperform at Wells Fargo... Newmont Mining (NEM) downgraded to Hold from Buy at Argus... SeaChange (SEAC) downgraded to Neutral from Buy at Dougherty... InterMune (ITMN) downgraded to Market Perform from Outperform at Leerink... Solar Senior Capital (SUNS) downgraded to Hold from Buy at BB&T... DreamWorks Animation (DWA) downgraded to Underweight from Neutral at Piper Jaffray... ARIAD (ARIA) downgraded to Neutral from Buy at Chardan.
News For DRH;BOOM;FMS;HUM;JAZZ;JNPR;NIHD;PSXP;SWY;TOL;VLP;VLRS;VNO;MSO;IZEA;FST;NEM;SEAC;ITMN;SUNS;DWA;ARIA From The Last 14 Days
|February 4, 2016|
|08:36 EDT||VLRS||Volaris reports preliminary January traffic up 31%|
Subscribe for More Information
|07:25 EDT||VLP||Valero Energy Partners expects 2016 CapEx $16M|
Consisting of $11M for maintenance and $5M for expansion.
|07:24 EDT||VLP||Valero Energy Partners reports Q4 EPS 59c, consensus 56c|
Subscribe for More Information
|February 1, 2016|
|16:21 EDT||DWA||On The Fly: Top stock stories for Monday|
Stocks began the session deep in negative territory, beginning February the way they spent most of January, weighed down by the price of oil, which fell about 6% for the session. Also hitting the market early were weak economic reports, both in China and the U.S. The averages moved higher late in the day as investors awaited the next barrage of earnings reports, which will include results from Google parent Alphabet (GOOG). ECONOMIC EVENTS: In the U.S., personal income rose 0.3% in December, versus expectations for an increase of 0.2%, while spending was flat, versus expectations for an increase of 0.1%. Markit's manufacturing purchasing managers index for January dipped to 52.4 in the final January reading, down from the 52.7 flash reading and below the 52.6 reading that was expected. The Institute for Supply Management's manufacturing index for January came in at 48.2, below the 48.4 that analysts expected. Construction spending rose 0.1% in December, which was weaker than the 0.6% increase that was forecast. Separately, Federal Reserve Vice Chairman Stanley Fischer spoke about recent monetary policy decisions undertaken by the Fed, reiterating expectations that "economic conditions will evolve in a manner that will warrant only gradual increases in the federal funds rate," while also revealing that four rate hikes is among the numbers being discussed by the Federal Reserve for this year. In China, the government's official manufacturing purchasing managers index fell to 49.4 in January from 49.7 in December. The private Caixin manufacturing PMI edged up to 48.4 from 48.2 in the prior reading, but both figures still remain in contraction territory. In Europe, Markit's manufacturing PMI for the euro zone dropped to 52.3 from December's 53.2, in-line with the earlier flash estimate. COMPANY NEWS: After swinging as high as $18.77, shares of Twitter (TWTR) ended the day up 6.55% at $17.90 after tech reporter Jessica Lessin said private equity firm Silver Lake and investor Marc Andreessen have "considered some sort of deal" for the microblog service operator, though Lessin noted she didn't know if deal talks are currently active. Later in the day, a source familiar with the matter told Fortune that Silver Lake has no interest in acquiring "even a slice" of Twitter... Alere (ALR) surged 45.5% to $54.11 after Abbott (ABT) agreed to acquire the company for $56 per share at a total expected equity value of $5.8B. In other M&A news, Questar (STR) jumped 22.5% to $24.99 after Dominion Resources (D) agreed to acquire it for $25 per share, or about $4.4B. Dominion slipped 2.76% after announcing the deal and reporting its latest quarterly results... Chipotle (CMG) rose 4.3% to $472.64 after the Centers for Disease Control and Prevention released its final update on the company's E. coli scare, saying the two outbreaks "appear to be over." MAJOR MOVERS: Among the notable gainers were Sysco (SYY) and Aetna (AET), which advanced 8.4% and 1.4%, respectively, after reporting quarterly earnings. Also higher was Barracuda Networks (CUDA), which jumped about 11% to $11.75 after Bloomberg reported the company is exploring a sale. In addition, Time Warner (TWX) gained 2.7% after the New York Post reported over the weekend that billionaire investor Nelson Peltz is considering taking an activist position in the company. Among the noteworthy losers was GoPro (GPRO), which declined 3.4% to $11.06 after analysts from Piper Jaffray and Citi predicted that the company's guidance this week will disappoint investors. Also lower was DreamWorks (DWA), which fell 6.8% to $23.90 after the studio's new film "Kung Fu Panda 3" missed expectations for its domestic box office opening. Meanwhile, Roper Technologies (ROP) and Cardinal Health (CAH) lost a respective 6.8% and 1.9% after reporting quarterly earnings. INDEXES: The Dow slipped 17.12, or 0.1%, to 16,449.18, the Nasdaq gained 6.41, or 0.14%, to 4,620.37, and the S&P 500 fell 0.86, or 0.04%, to 1,939.38.
|12:58 EDT||DWA||DreamWorks falls after Piper says 'Kung Fu Panda 3' missed expectations |
Shares of DreamWorks Animation (DWA) dropped in midday trading after an analyst from Piper Jaffray said that the studio's new film "Kung Fu Panda 3" slightly underperformed his expectations, despite having topped the U.S. box office in its opening weekend. WHAT'S NEW: DreamWorks' newest picture "Kung Fu Panda 3," starring Jack Black, Dustin Hoffman and Angelina Jolie, topped the U.S. box office this past weekend after its release Friday, grossing $41M domestically. The film was produced by DreamWorks and distributed by 21st Century Fox (FOX), which also distributed the weekend runner-up "The Revenant," which grossed $12.4M in the U.S. WHAT'S NOTABLE: The first two films in the "Kung Fu Panda" franchise took in $60.2M and $47.6M, respectively, in their opening weekends and grossed a total of nearly $1.3B worldwide. 'SLIGHT' UNDERPERFORMANCE: Commenting on the movie's performance over the weekend, Piper Jaffray analyst James Marsh said in a note to clients that the movie's $41M debut figure was "solid" but still slightly missed the firm's expectations of $45M-$50M. Marsh noted that the movie grossed an "impressive" $58M in China, which set a new opening record for an animated movie in that region. The analyst added that "Kung Fu Panda 3" should still have a solid run over the next few weeks due to good reviews, minimal competition, President's weekend domestically and a Chinese New Year holiday abroad. Marsh maintained an Overweight rating and $31 price target on DreamWorks Animation. RECENT DOWNGRADE: Last week, Topeka analyst David Miller downgraded DreamWorks Animation to Sell from Hold with a $19 price target ahead of the "Kung Fu Panda 3" release, citing valuation. Miller said that shares had already reflected expectations for the movie and recommended that investors trim their positions. PRICE ACTION: In afternoon trading, DreamWorks Animation fell 6.7% to $23.92.
|12:27 EDT||DWA||Options with increasing put volume|
Subscribe for More Information
|09:08 EDT||JAZZ||Jazz Pharmaceuticals reports data from Phase 3 pivotal study of defibrotide|
Jazz Pharmaceuticals announced that data from the phase 3 pivotal study of defibrotide were published online in BLOOD, the Journal of the American Society of Hematology, or ASH. The data demonstrated that defibrotide use in patients with hepatic veno-occlusive, or VOD, also known as sinusoidal obstruction syndrome, with multi-organ failure post-hematopoietic stem-cell transplantation was associated with a statistically significant improvement in Day +100 survival and in rate of complete response by Day +100, compared with rigorously selected historical controls.
|08:09 EDT||DWA||Options expected to be active|
Options expected to be active: GOOGL GOOG YHOO UPS KORS UPS BAX RCL CCL PFE AET D STR DWA CMG ABT SYK.
|07:37 EDT||ARIA||ARIAD announces FDA clearance to begin development of AP32788|
Subscribe for More Information
|06:27 EDT||DWA||Kung Fu Panda 3 slightly missed expectations, says Piper Jaffray|
Piper Jaffray analyst James Marsh says the $41M opening weekend for DreamWorks Animation's Kung Fu Panda 3 slightly underperformed his expectation of $45-$50M. The film, however, grossed an "impressive" $58M in China, Marsh tells investors in a research note. He remains a buyer of DreamWorks shares with an Overweight rating.
|06:03 EDT||HUM||Aetna on track to close Humana transaction in 2H16|
The company commented, "We continue to work diligently with the Department of Justice and state regulators toward final approval of our proposed acquisition of Humana, and we continue to advance our integration readiness plans. We have obtained seven of the necessary state approvals, and we believe we remain on track to close the transaction in the second half of 2016."
|January 31, 2016|
|18:07 EDT||DWA||'Kung Fu Panda 3' swings to first, 'Finest Hours' lands in choppy waters|
"Kung Fu Panda 3" topped the box office in its U.S. debut while nautical disaster drama "The Finest Hours" floundered. WEEKEND LEADER: "Kung Fu Panda 3," produced by DreamWorks (DWA) and distributed by Fox (FOX, FOXA), grossed $41M against expectations for $35M-$50M in its domestic debut during the weekend of January 31. The computer-animated action comedy, featuring the voices of Jack Black, Dustin Hoffman and Angelina Jolie, set a new box office record for January animated film openings but fell somewhat short of the $60.2M and $47.7M debuts seen by previous films in the franchise. BOX OFFICE RUNNERS-UP: "The Revenant," also from Fox, grossed $12.4M. Disney's (DIS) "Star Wars: The Force Awakens" took in an additional $10.8M and stands at $1.98B globally, while the company's "The Finest Hours" earned $10.3M in its domestic start despite an estimated $70M-$80M budget. Rounding out the top five was Universal's (CMCSA, CMCSK) "Ride Along 2" with $8.3M.
|January 29, 2016|
|14:24 EDT||HUM||Earnings Watch: Aetna down 9% since last report|
Aetna (AET) is scheduled to report fourth quarter earnings before the market open on Monday, February 1, with a conference call scheduled for 8:30 am ET. Aetna, a diversified health care benefits company in the United States, operates in three segments: Health Care, Group Insurance, and Large Case Pensions. EXPECTATIONS: Analysts are looking for earnings per share of $1.21 on revenue of $14.93B, according to First Call. The consensus range for EPS is $1.16-$1.32 on revenue of $14.44B-$15.36B. LAST QUARTER: Aetna reported third quarter EPS of $1.90 on revenue of $14.97B against analyst estimates of $1.77 and $14.95B, respectively. The company raised its fiscal 2015 EPS view to $7.45-$7.55 from "at least $7.40." Operating earnings were $668.6M for Q315 compared with $638.6M for Q314. The increase in operating earnings was primarily due to higher underwriting margins in Aetna's Health Care segment, partially offset by an increase in general and administrative expenses and lower underwriting margins in Aetna's Group Insurance segment. On January 11, Aetna said it see FY15 EPS at the high end of the $7.45-$7.55 range. Consensus for FY15 EPS is $7.54. STREET RESEARCH: On January 15, Wells Fargo said it expects health insurers' stock to do well this year, as the firm expects M&A deals made the last years to increase profits this year, and it thinks investors should be attracted to what it sees as the defensive names in the sector. Wells does not believe that any changes to or replacements of the ACA will be worse for the sector than the status quo. It identified Aetna and HCA Holdings (HCA) as its favorite names in the sector. On January 25, Leerink analyst Ana Gupte said she believed the recent selloff has provided a "strong" buying opportunity in the Managed Care space. Valuations are attractive on multiple metrics, Gupte told investors in a research note. Her top picks are UnitedHealth (UNH), Aetna, Humana (HUM) and Molina Healthcare (MOH). The analyst also favors Anthem (ANTM) and Cigna (CI). PRICE ACTION: Shares of Aetna are down approximately 9% since its last earnings report. The stock is up 2.6% to $101.42 in Friday afternoon trading ahead of Monday morning's report.
|12:53 EDT||DWA||Box Office Battle: 'Kung Fu Panda 3' expected to kick 'Revenant' from top spot|
DreamWorks Animation's (DWA) "Kung Fu Panda 3" featuring Jack Black is expected to break the record for the largest January opening for an animated feature, topping the opening of "The Nut Job" in 2014. The first two films in the "Kung Fu Panda" franchise took in $60.2M and $47.6M, respectively, in their opening weekends and grossed a total of nearly $1.3B worldwide. With a strong base of Po the Panda fans and the popularity of a recent TV show, conservative early estimates say "Panda 3" is expected to bring in $35M-$50M. Also opening this weekend are Disney's (DIS) "The Finest Hours," starring Chris Pine, and Open Road Films' "Fifty Shades of Black," starring Marlon Wayans. "The Finest Hours" may disappoint, with expectations topping out at $10M in its opening weekend. "Fifty Shades of Black," meanwhile, is the latest spoof movie from the team of Wayans and Michael Tiddes from "Haunted House" fame. The last film from Wayans had an opening weekend of $8.8M, and this one is currently expected to take in a similar amount. Both films will battle with Fox's (FOX, FOXA) survival story and Oscar contender "The Revenant," starring Leonardo Dicaprio, and Disney's (DIS) "Star Wars: The Force Awakens" for spots in the top five. "The Revenant" and "Star Wars" should each take in $9M-$12M even as they continue to lose theaters this coming weekend. Other publicly traded companies involved in filmmaking include Lionsgate (LGF), Comcast (CMCSA, CMCSK), and Sony (SNE).
|10:36 EDT||NEM||Active puts @ CBOE: IWM VMW NEM SPY XRT AAPL|
Subscribe for More Information
|10:05 EDT||JNPR||On The Fly: Analyst Upgrade Summary|
Today's noteworthy upgrades include: Atlassian (TEAM) upgraded on positive outlook at JMP Securities... BRF S.A. (BRFS) upgraded to Buy from Hold at Deutsche Bank... Bank of America (BAC) upgraded to Outperform from Sell at CLSA... CEMEX (CX) upgraded to Buy from Hold at Jefferies... Chemical Financial (CHFC) upgraded to Outperform from Market Perform at Fig Partners... Computer Programs (CPSI) upgraded to Buy from Hold at Topeka... DST Systems (DST) upgraded to Outperform at Baird... Diamond Offshore (DO) upgraded to Neutral from Sell at Citi... First Cash Financial (FCFS) upgraded to Buy from Neutral at Janney Capital... First Merchants (FRME) upgraded to Overweight from Equal Weight at Stephens... Flex (FLEX) upgraded on solid results at Stifel... Intercept (ICPT) upgraded to Equal Weight from Underweight at Morgan Stanley... J.C. Penney (JCP) upgraded to Neutral from Underperform at Credit Suisse... JetBlue (JBLU) upgraded to Buy from Hold at Evercore ISI... Juniper (JNPR) upgraded to Outperform from Market Perform at Bernstein... Live Oak Bancshares (LOB) upgraded to Buy from Neutral at SunTrust... Microsemi (MSCC) upgraded to Outperform from Market Perform at Wells Fargo... NetSuite (N) upgraded to Buy from Hold at Canaccord... NextEra Energy (NEE) upgraded to Outperform at Baird... Oshkosh (OSK) upgraded to Buy from Neutral at SunTrust... PC Connection (PCCC) upgraded to Market Perform from Underperform at Raymond James... Pinnacle Financial (PNFP) upgraded to Overweight from Equal Weight at Stephens... Potash (POT) upgraded to Outperform from Sector Perform at Scotiabank... Rayonier (RYN) upgraded on valuation at BMO Capital... SanDisk (SNDK) upgraded to Buy from Hold at Needham... Select Comfort (SCSS) upgraded to Outperform from Neutral at Wedbush... Sotherly Hotels (SOHO) upgraded to Buy from Neutral at Janney Capital... Textura (TXTR) upgraded to Outperform from Market Perform at Northland... Valley National (VLY) upgraded to Buy from Hold at Sandler O'Neill.
|07:03 EDT||PSXP||Phillips 66 Partners 'on track' to deliver 5-year distribution growth-rate goal|
Subscribe for More Information
|07:02 EDT||PSXP||Phillips 66 Partners reports Q4 EPS 61c, consensus 53c|
Subscribe for More Information
|06:55 EDT||JAZZ||2016 could be pivotal year for Jazz, says Deutsche Bank|
Deutsche Bank analyst Gregg Gilbert says 2016 could be a pivotal year for Jazz Pharmaceuticals. The analyst sees several potential catalysts for the shares, including potentially greater certainty on Xyrem duration via a patent settlement or a win in court, FDA approval of defibrotide and acquisitions supported by the company's under-leveraged balance sheet. Gilbert keeps a Buy rating on Jazz with a $167 price target.
|06:53 EDT||JNPR||Juniper upgraded to Outperform from Market Perform at Bernstein|
Bernstein analyst Pierre Ferragu upgraded Juniper to Outperform with a $31 price target on shares. The analyst said shares have fallen to attractive levels while fundamentals are strong and stable to improving. Ferragu said the cautious Q1 guidance reflects management being prudent given the uncertain macro environment and reminds investors 65% of revenues come from the Service Provider market, which means the company will benefit from late cycle exposure and could surprise to the upside, at least initially. Furthermore, the analyst said the CFO resignation and transition had been in the plans for some time and presents no risk.